Improving Palliative Care for Patients with Cancer

改善癌症患者的姑息治疗

• 批准号: 7008103
• 负责人: MARK T HEGEL
• 金额: $ 60.49万
• 依托单位: DARTMOUTH COLLEGE
• 依托单位国家: 美国
• 财政年份: 2003
• 资助国家: 美国
• 起止时间: 2003-01-23 至 2007-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7008103
• 关键词: breast neoplasms; clinical research; gastrointestinal neoplasms; health care quality; health education; health services research tag; human therapy evaluation; lung neoplasms; neoplasm /cancer palliative treatment; patient care personnel relations; patient oriented research; quality of life; self care; telemedicine; terminal patient care

DESCRIPTION: (Provided by applicant) The recent report of the Institute of Medicine concludes that there is a critical need for research designed to improve care at the end of life. Project ENABLE, a Robert Wood Johnson funded demonstration project designed to improve end-of-life care in cancer patients, showed that a palliative care model that focused on early intervention (at the time of diagnosis of advanced cancer), patient education, preference- based treatment and coordinated care is: 1) feasible to implement in a comprehensive cancer center; 2) accepted by oncologists who are focused on aggressive/clinical trials- oriented care; and 3) accepted and valued by patients and family members. This application is designed to refine the ENABLE intervention and increase its efficiency by integrating approaches developed by the Dartmouth Northern New England Cooperative Research Group that have focused on practice system changes that improve quality and efficiency of care. The primary goal of this application is to test the efficacy of an intervention for improving palliative care for cancer patients that includes: 1) the Dartmouth Clinical Improvement System which emphasizes rapid assessment of problems and feedback to patients (including tailored educational materials) and practitioners; 2) telephone- base nurse educators who will provide ongoing symptom and problem assessment, coordination of care between the cancer center health care team and other services, and education regarding problem-solving, communication with the healthcare team, advanced care planning and symptom management; and 3) Drop-In Group Medical Appointments (DIGMAs) for symptom management. Patients with advanced lung, gastrointestinal, and breast cancer seen at the Norris Cotton Cancer Center will be identified at diagnosis and randomized to receive the ENABLE II intervention or standard care. The primary hypotheses are: 1) Patients randomized to the ENABLE II intervention will report better symptom management, higher quality of life, a better match between preferences and the care received, and lower health care utilization as compared to patients in the standard care group and 2) Family members of patients receiving the ENABLE II intervention will report better quality of care, symptom management, and match between preferences and care received as measured by the After Death Interview.

产品说明：（申请人提供）医学研究所最近的报告得出结论，迫切需要进行旨在改善生命末期护理的研究。由罗伯特·伍德约翰逊资助的旨在改善癌症患者临终关怀的示范项目“ENABLE项目”表明，注重早期干预的姑息治疗模式（在诊断晚期癌症时），患者教育，基于偏好的治疗和协调护理是：1）在综合性癌症中心实施是可行的; 2）被专注于积极/临床试验导向护理的肿瘤学家所接受; 3）被患者和家属所接受和重视。该应用程序旨在通过整合达特茅斯北方新英格兰合作研究小组开发的方法来完善ENABLE干预并提高其效率，该研究小组专注于提高护理质量和效率的实践系统变化。本申请的主要目的是测试改善癌症患者姑息治疗的干预措施的有效性，该干预措施包括：1）达特茅斯临床改善系统，该系统强调对问题的快速评估和对患者的反馈（包括量身定制的教育材料）和从业人员; 2）电话护士教育者，他们将提供持续的症状和问题评估，协调癌症中心卫生保健小组和其他服务之间的护理，和教育有关的问题解决，与医疗团队的沟通，先进的护理计划和症状管理;和3）下降组医疗咨询（DIGMA）的症状管理。在Norris Cotton癌症中心就诊的晚期肺癌、胃肠道癌和乳腺癌患者将在诊断时被确定，并随机接受ENABLE II干预或标准治疗。主要假设是：1）与标准护理组的患者相比，随机分配至ENABLE II干预组的患者将报告更好的症状管理、更高的生活质量、偏好与接受的护理之间更好的匹配以及更低的医疗保健利用率，以及2）接受ENABLE II干预的患者的家庭成员将报告更好的护理质量、症状管理、以及通过死后访谈测量的偏好和接受的护理之间的匹配。